Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Clinical trial NCT00004064 · UNKNOWN

Trial details

NCT number: NCT00004064
Sponsor: AltaRex
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1998-11-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.